|
ELK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1090999999519E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.48909999997393E-06 |
| Normal-vs-Stage2 |
8.572100E-02 |
| Normal-vs-Stage3 |
6.557300E-04 |
| Normal-vs-Stage4 |
1.801520E-02 |
| Stage1-vs-Stage2 |
3.016800E-01 |
| Stage1-vs-Stage3 |
7.923400E-01 |
| Stage1-vs-Stage4 |
4.733200E-01 |
| Stage2-vs-Stage3 |
4.563400E-01 |
| Stage2-vs-Stage4 |
7.763400E-01 |
| Stage3-vs-Stage4 |
6.414400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13650000030685E-07 |
| Normal-vs-AfricanAmerican |
5.795800E-03 |
| Normal-vs-Asian |
8.299900E-03 |
| Caucasian-vs-AfricanAmerican |
2.992200E-01 |
| Caucasian-vs-Asian |
9.245000E-01 |
| AfricanAmerican-vs-Asian |
3.770000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.037600E-03 |
| Normal-vs-Female |
4.34840000007597E-07 |
| Male-vs-Female |
1.416990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.09969999953996E-07 |
| Normal-vs-Age(41-60Yrs) |
1.587220E-04 |
| Normal-vs-Age(61-80Yrs) |
3.278400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.555800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.565820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.940300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.537600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.820800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.381600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.468600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.482000E-01 |
| Classical-VS-Follicular |
1.86740001240082E-09 |
| Classical-VS-Other |
4.957500E-02 |
| Classical-VS-Normal |
1.43159994969722E-09 |
| Tall-VS-Follicular |
4.793300E-04 |
| Tall-VS-Other |
3.715500E-02 |
| Tall-VS-Normal |
1.199680E-03 |
| Follicular-VS-Other |
7.596600E-01 |
| Follicular-VS-Normal |
7.187600E-01 |
| Other-VS-Normal |
5.414200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.155200E-03 |
| Normal-vs-N1 |
8.682100E-03 |
| N0-vs-N1 |
5.891600E-01 |
|
|
